Higher radiation dose tested to fight aggressive brain cancer in seniors
NCT ID NCT06835803
Summary
This study is testing whether giving a higher daily dose of radiation over three weeks works better than the standard dose for older adults with a newly diagnosed aggressive brain tumor called glioblastoma. Researchers will compare survival, side effects, and quality of life between the two treatment groups. The goal is to find a more effective radiation schedule for patients aged 65 and older.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dana-Farber Brigham Cancer Center, Milford Hospital
RECRUITINGMilford, Massachusetts, 01757, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Dana-Farber Brigham Cancer Center, South Shore Hospital
RECRUITINGSouth Weymouth, Massachusetts, 02190, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.